Incyte Switzerland

Incyte aims to become one of the world's leading biopharmaceutical companies. Founded on the belief that investment in high-quality science and an unwavering pursuit of R&D excellence can lead to novel medicines that positively impact patients' lives, Incyte is headquartered in Wilmington, Delaware, USA. With over 2,600 employees, the company operates in North America, Europe, and Asia. Incyte Biosciences International Sàrl is its Swiss branch.